Court Rules For Pfizer In Accupril Patent Suit
A U.S. district court judge has ruled that Pfizer's patents for Accupril are valid, dealing Israeli drug maker Teva a blow in its efforts to market a generic version of the...To view the full article, register now.
Already a subscriber? Click here to view full article